Pharmacovigilance Information

A Drug Safety & Medicines Information Resource
Welcome 
PharmacovigilanceInfo provides information on pre- and post- marketing pharmacovigilance in the UK, Europe & the USA.
The Concept of Pharmacovigilance

Before a new drug is authorised for sale to members of the public, it undergoes years of testing in both animals (pre-clinical) and human beings (clinical trials). These tests are done in order to understand how the drug will potentially work in humans and what adverse effects are likely to occur...To learn more about pharmacovigilance and its applications, click here.     

Report a side effect with a medicine

       UK Yellow Card Scheme

 

MedWatch logo US FDA Adverse Event Reporting Program
Site News

Drug safety alerts and other relevant information can now be sent directly to your email inbox. To subscribe, please enter your email address in the subscription box on this page.  

Latest pharmacovigilance topic titled "Reference safety information" published. Please see the topics section for details.

Pharmacovigilanceinfo subscription service launched. Please see the services section for details.

FDA Medwatch Updates

only search pharmacovigilanceinfo.com

 

Counter
FDA MedWatch Learn
Do you need to report problems to the FDA?
 If so, click here to
practise the completion of Forms FDA 3500 and 3500B

Medicines info resources are available here.
POLL
A JAMA study recently revealed that the FDA delays the release of AE data to the public by as much as 7 mths. Do you think this is warranted?
- No, it exposes more patients to potentially avoidable serious harm
- Yes, it takes a considerable amount of time to evaluate safety data
- No, this is inexcusable. The FDA should lead by example
- Yes, the FDA can take as long as it needs as it is the drug regulator
- No need to panic as the FDA will notify the public if a drug poses imminent danger
- Itís all relative
  
Useful links

Enter your email address in the box below to receive drug alerts & recalls: